Dose escalation study of proton beam therapy with concurrent chemotherapy for stage III non‐small cell lung cancer

The purpose of this study is to determine the recommended dose (RD) of proton beam therapy (PBT) for inoperable stage III non‐small cell lung cancer (NSCLC). We tested two prescribed doses of PBT: 66 Gy (relative biological effectiveness [RBE]) in 33 fractions and 74 Gy (RBE) in 37 fractions in arms...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Sci
Autors principals: Harada, Hideyuki, Fuji, Hiroshi, Ono, Akira, Kenmotsu, Hirotsugu, Naito, Tateaki, Yamashita, Haruo, Asakura, Hirofumi, Nishimura, Tetsuo, Takahashi, Toshiaki, Murayama, Shigeyuki
Format: Artigo
Idioma:Inglês
Publicat: John Wiley and Sons Inc. 2016
Matèries:
Original Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4946725/
https://ncbi.nlm.nih.gov/pubmed/27110950
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12955
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars